Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different concentrations of ropivacaine for postoperative analgesia after nerve block or local infiltration in non-head/neck, non-cardiac surgery
ChiCTR2400089329Phase 4Recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Sep 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine in postoperative incisional pain (8 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: Cumulative sufentanil use 0–72 hours. Started Sep 2024; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative incisional pain
Beyond the preview
Go deeper on ChiCTR2400089329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089329.